Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

Overview ForecastFinancials Chart Transcripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 21.16% institutional investors, 9.47% insiders, and 69.37% retail investors. Suvretta capital management is the largest institutional shareholder, holding 8.22% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.58% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Capricor Therapeutics	21.16%	9.47%	69.37%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.80%	11.85%	52.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	3.82M	8.22%	$116.09M
Blackrock funding, inc. /de	3.42M	7.36%	$104.02M
Tang capital management	3.40M	7.32%	$103.36M
Vanguard group	2.56M	5.60%	$73.94M
Blackrock	1.63M	5.19%	$7.77M
State street	2.18M	4.69%	$66.33M
Ra capital management	1.51M	3.24%	$45.84M
Geode capital management	1.12M	2.41%	$34.00M
Goldman sachs group	911.98K	1.96%	$27.72M
Point72 asset management	821.18K	1.77%	$24.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tang capital management	3.40M	5.25%	$103.36M
Dg capital management	392.10K	3.65%	$11.92M
Suvretta capital management	3.82M	2.96%	$116.09M
Boxer capital management	590.00K	2.35%	$17.94M
Ikarian capital	528.01K	1.30%	$16.05M
Moody aldrich partners	226.03K	1.24%	$6.87M
Palo alto investors lp	229.76K	1.07%	$6.98M
Ra capital management	1.51M	0.49%	$45.84M
J. goldman & co lp	541.52K	0.48%	$16.46M
Diadema partners lp	78.85K	0.41%	$2.40M

Top Buyers

Holder	Shares	% Assets	Change
Suvretta capital management	3.82M	2.96%	2.03M
Tang capital management	3.40M	5.25%	1.70M
State street	2.18M	0.00%	1.35M
Blackrock	1.63M	0.00%	1.25M
Blackrock funding, inc. /de	3.42M	0.00%	570.84K

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	821.18K	0.03%	-1.02M
Darwin global management	-	-	-800.00K
Altium capital management lp	-	-	-714.00K
Soleus capital management	-	-	-646.39K
Octagon capital advisors lp	-	-	-450.00K

New Positions

Holder	Shares	% Assets	Change	Value
Mercer global advisors inc /adv	403.00K	0.02%	403.00K	$12.25M
Vanguard fiduciary trust	320.10K	0.00%	320.10K	$9.73M
Trexquant investment lp	222.41K	0.05%	222.41K	$6.76M
Integral health asset management	200.00K	0.29%	200.00K	$6.08M
Walleye capital	177.54K	0.02%	177.54K	$5.40M

Sold Out

Holder	Change
True wealth design	-5.00
Bare financial services	-17.00
Northwestern mutual wealth management	-19.00
C m bidwell & associates	-43.00
Federated hermes	-68.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	98	-34.67%	10,338,441	-62.30%	21	0.59%	72	-19.10%	13	-70.45%
Dec 31, 2025	73	-47.86%	11,993,578	-17.25%	26	2.61%	45	-30.77%	24	-33.33%
Sep 30, 2025	136	-	14,466,244	5.28%	31	3.50%	62	-6.06%	36	-7.69%
Jun 30, 2025	132	-7.04%	13,682,657	-27.15%	29	1.77%	63	-24.10%	40	37.93%
Mar 31, 2025	10	-92.48%	930,147	-94.63%	2	0.08%	7	-92.39%	2	-86.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.49M	2.58%	24.87K
State Street® SPDR® S&P® Biotech ETF	1.29M	2.23%	-12.93K
Vanguard US Total Market Shares ETF	872.18K	1.91%	-
iShares Russell 2000 ETF	1.02M	1.77%	8.60K
SPDR® S&P Biotech ETF	584.18K	1.28%	1.30K
Vanguard Institutional Extnd Mkt Idx Tr	519.07K	0.90%	4.71K
Fidelity Small Cap Index	376.88K	0.65%	3.97K
iShares Russell 2000 Growth ETF	356.50K	0.62%	918.00
Fidelity Select Biotechnology	314.70K	0.54%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	227.13K	0.50%	1.15K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 01, 2026	Krasney Karen	EVP, GENERAL COUNSEL	Sell	$792.55K
May 01, 2026	Bergmann Anthony	CHIEF FINANCIAL OFFICER	Sell	$792.54K
Apr 02, 2026	Sabar Karimah Es	-	Sell	$240.93K
Mar 31, 2026	Krasney Karen	EVP, GENERAL COUNSEL	Sell	$752.93K
Mar 31, 2026	Sabar Karimah Es	-	Sell	$1.85M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	4
2026 Q1	-	3
2025 Q4	-	-
2025 Q1	-	-
2024 Q4	-	-

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 21.16%, followed by 9.47% insiders and 69.37% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 35.80%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Suvretta capital management (3.82M shares, 8.22%), Blackrock funding, inc. /de (3.42M shares, 7.36%), and Tang capital management (3.4M shares, 7.32%). Together, they hold 22.89% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Tang capital management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.25% of its assets in 3.4M Capricor Therapeutics shares, valued at 103.36M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.58% of its total shares outstanding invested in 1.49M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools